Exane Derivatives’s Cloudera, Inc. CLDR Stock Holding History

Exane Derivatives’s Portfolio CLDR Stock Details CLDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-62	Closed	-$990	–	1124
2021 Q3	$990	Hold	62	–	–	﹤0.01%	864
2021 Q2	$964	Sell	62 -1,205	-95%	-$16.4K	﹤0.01%	880
2021 Q1	$15.4K	Sell	1,267 -931	-42%	-$13.9K	﹤0.01%	582
2020 Q4	$30.6K	Hold	2,198	–	–	0.01%	497
2020 Q3	$23.9K	Sell	2,198 -11,477	-84%	-$133K	0.01%	422
2020 Q2	$174K	Buy	+13,675	New	+$131K	0.05%	225

Exane Derivatives's CLDR Position: Q4 2021 in Review

Exane Derivatives sold out of Cloudera, Inc. (CLDR) in Q4 2021, closing a stake of 62 shares — an estimated $990 sold.

Exane Derivatives first reported a position in CLDR in Q2 2020 and held it in 6 quarters. The position peaked at $174K in Q2 2020. 0 funds tracked by Wall St. Rank hold CLDR as of Q4 2021.

Exane Derivatives reported no remaining Cloudera, Inc. position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 62 Cloudera, Inc. shares in Q4 2021, an estimated $990.
Exane Derivatives first reported a position in Cloudera, Inc. in Q2 2020 and held it in 6 quarters.
Exane Derivatives's Cloudera, Inc. position peaked at $174K in Q2 2020.
0 funds tracked by Wall St. Rank held Cloudera, Inc. as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.